Search results for " market" in Articles / App Notes
Article
From Darwin to Recombinant Fc Multimers
IgG market will continue to dominate with 46% of market, followed by albumin, 18%, John Perkins stressed the importance of other plasma proteins to have a good process economy.
Some of the …
Article
Milestones and Moderate Progress in 2012 Drug Approvals
Twelve biopharmaceutical marketing applications were approved in the United States and/or the European Union in 2012 (see Table I). Approval numbers for the past year are in line with those recorded o…
Article
Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
By Claire Hill
The biopharmaceutical market continues to expand at a rapid pace and the demand for upstream manufacturing capacity, particularly for growth areas such as viral vectors, is growing …
Article
ADC Development Robust Despite Lackluster Performance
The road to market has been difficult, however, with only three ADC products approved for sale by FDA in the United States as of October 2017. This has not stopped ADC developers, though, and the biop…
Article
Platform Technologies Improve Protein Expression
Challener
Speed to market is essential in the biopharmaceutical industry today. Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the…
Article
The New World of Biopharmaceutical Manufacturing
…r turnaround between products and batches, resulting in reduced capital costs and increased speed to market. Single-use technology has also precipitated changes in upstream and downstream processing.…
Article
Biosimilars to Drive Modern Manufacturing Approaches
By Jill Wechsler
As more biosimilars gain market approval in the United States, and manufacturers launch additional programs to develop competitive biotech therapies, regulatory authorities and in…
Article
Labeling of Biosimilars
…eached a key stage in the lengthy process of creating a regulatory framework for the development and marketing of biosimilars in Europe. In December 2014, guidelines on quality standards for biosimil…
Article
Optimizing Resin Performance with Disposable Chromatography Solutions
…r product manager of antibody affinity media, Cytiva; and Steve Tingley, vice-president of sales and marketing, bioprocessing, Repligen about current trends in disposable chromatography and how the t…
Article
Bureaucratic Roadblocks Threaten Biopharma Growth
…dermine the drug development and patenting process and may impede the delivery of novel medicines to market.
Despite the 2010 declaration by the then-President of India that the next 10 years w…